BioRestorative Therapies, Inc. BRTX shares are trading lower by 55% to $1.56 during Tuesday’s session following Monday’s surge after the company announced agreements with certain holders of its existing warrants to exercise them at a reduced price of $2.33 per share, totaling approximately $8.1 million in gross proceeds.
This exchange involves issuing new warrants. The transaction was structured as an at-market transaction under Nasdaq rules, with Roth Capital Partners serving as the company’s financial advisor.
See Also: China Stocks Surge After Beijing Announces New Measures
According to data from Benzinga Pro, BRTX has a 52-week high of $7.13 and a 52-week low of $1.40.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
